Matsushita Electric Industrial Co. and its rival Samsung Electronics have settled all ongoing patent infringement suits in the United States and Japan over semiconductor technology, the companies announced Wednesday.
Citing New Jersey's natural interest in a hazardous-waste-contaminated property that lies within its own borders, the New Jersey Supreme Court on Tuesday exercised jurisdiction over an insurance coverage dispute, affirming an earlier appellate court ruling.
On the order of the U.S. Supreme Court, a federal judge has reopened a decade-old lawsuit brought by DuPont against the government for recovery of environmental cleanup costs.
A district court has conditionally certified a collective action against bus company Coach USA Inc. by bus dispatchers who say they were wrongly classified as exempt from the overtime pay requirements of the Fair Labor Standards Act.
After failing to reach an agreement with Teva Pharmaceutical Industries Ltd., Wyeth has announced it will launch its own generic version of its heartburn drug, Protonix.
There seems to be no letup in FLSA litigation. If a company has employees, it is a potential target for a wage-and-hour lawsuit, says Kelley Drye & Warren's Barbara E. Hoey in our series of chats with high-profile employment lawyers.
Sonnenschein Nath & Rosenthal LLP has lured a veteran trial attorney from Locke Lord Bissell & Liddell LLP into the fold at its Dallas office, a move that litigator Michael Moore says comes as national firms are increasingly seeking to establish or bolster their presence in Texas.
A Delaware federal judge has refused to dismiss or transfer four Boston Scientific Corp. lawsuits that seek to invalidate Johnson & Johnson patents for drug-eluting coronary stents.
Medical device maker Synthes (USA) should be held accountable for selling faulty bone plates that are prone to shredding a patient's ligaments, a proposed class action has charged.
A federal court judge has closed the book on the consolidated securities litigation filed in the wake of the fraud at Cendant Corp., dismissing the final suit against the company and tossing out a slew of claims and counterclaims filed by the company itself.
A Bausch & Lomb contact lens solution that caused a massive outbreak of fungal infections in 2006 may not have been adequately tested to ensure that it was resistant to microbial contamination, a study has found.
A bankrupt consulting firm accused of overbilling clients in asbestos-related bankruptcies wants to shield a Heller Ehrman LLP investigative report into the firm's billing practices from the public.
A proposed class action launched Wednesday by ABM International Inc. is accusing a slew of shipping companies, including Federal Express Corp. and United Parcel Service Inc., of conspiring to fix fuel surcharge prices in order to reap illegal profits.
Sprint Corp. has lost a second attempt to dismiss a securities fraud action over a tax shelter scheme, with a federal judge ruling that the lawsuit satisfied the court's heightened pleading standard.
Apotex Corp. will collect $5 million in wrongful injunction damages after successfully defending an infringement case brought by Daiichi Sanko Co. Ltd. over a patent covering antibacterial ear medicine.
Royal Dutch Shell PLC will pay Bernstein Liebhard & Lifshitz LLP, the lead counsel in a class action filed by U.S. shareholders against the oil giant for its 2004 reserves restatements, a $27 million fee for helping work out a settlement agreement.
While currently defending itself against a national wage-and-hour class action, financial services company Washington Mutual Inc. has been hit with a related proposed class action, seeking to represent loan consultants who missed the deadline to opt in to the first suit.
A New Jersey congressman has introduced legislation to clarify U.S. Department of Justice rules on a type of settlement federal prosecutors increasingly enter into with corporations, amid questions over whether favoritism has become part of the process.
Accusing the U.S. Environmental Protection Agency of dragging its feet, a coalition of attorneys general is putting pressure on the agency to quickly address the question of regulating greenhouse gas emissions, as ordered in a Supreme Court decision last spring.
Generics drugmaker Barr Pharmaceuticals Inc. announced Tuesday it was in negotiations with a Johnson & Johnson unit to resolve a four-year patent dispute over blockbuster oral contraceptive pill Ortho Tri-Cyclen.